Global Continuous Subcutaneous Insulin Infusion Devices Market Research Report 2026(Status And Outlook)

Buy Now
Share to
Facebook
Twitter
LinkedIn
WhatsApp
Base Year
2026
Forecast Period
2024-2029
Pages
139
Industry
Medical Devices
Regions
Global
Updated
February 2026

Report Overview


Report Overview
Continuous Subcutaneous Insulin Infusion Devices is a medical device used for the administration of insulin in the treatment of diabetes mellitusThe Insulin Pen and Pump market is primarily driven by the increasing prevalence of diabetes and the need for convenient and accurate insulin delivery methods. Insulin pens and pumps offer user-friendly options for individuals with diabetes to manage their blood sugar levels effectively. The growing awareness of diabetes management, coupled with the advantages of improved dosing accuracy, reduced needle injections, and better glycemic control, contributes to market growth. Moreover, the trend towards personalized medicine and the demand for discreet and easy-to-use devices further propel adoption. However, challenges include patient adherence to treatment regimens, addressing potential technical issues with pumps, and ensuring proper insulin storage for pens. Navigating the competitive landscape and providing education on proper device usage are ongoing concerns. The markets success relies on continuous innovation to enhance device features, comprehensive patient education on insulin management, and collaborations between medical device manufacturers and healthcare professionals to offer reliable, user-centric, and effective insulin pen and pump solutions while addressing the evolving challenges associated with diabetes management.

The global Continuous Subcutaneous Insulin Infusion Devices market size was estimated at USD 4703.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.30% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Continuous Subcutaneous Insulin Infusion Devices market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Continuous Subcutaneous Insulin Infusion Devices market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Continuous Subcutaneous Insulin Infusion Devices market.
Global Continuous Subcutaneous Insulin Infusion Devices Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Medtronic
Roche
Insulet Corp
Tandem Diabetes care
Valeritas
SOOIL
Microport

Market Segmentation (by Type)
Normal Pump
Patch Pump

Market Segmentation (by Application)
Type I Diabetes
Type II Diabetes

Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Continuous Subcutaneous Insulin Infusion Devices Market
Overview of the regional outlook of the Continuous Subcutaneous Insulin Infusion Devices Market:

Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Continuous Subcutaneous Insulin Infusion Devices Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the markets competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porters five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Continuous Subcutaneous Insulin Infusion Devices, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.



Table of Contents

  • 1 Research Methodology and Statistical Scope
    • 1.1 Market Definition and Statistical Scope of Continuous Subcutaneous Insulin Infusion Devices
    • 1.2 Key Market Segments
      • 1.2.1 Continuous Subcutaneous Insulin Infusion Devices Segment by Type
      • 1.2.2 Continuous Subcutaneous Insulin Infusion Devices Segment by Application
    • 1.3 Methodology & Sources of Information
      • 1.3.1 Research Methodology
      • 1.3.2 Research Process
      • 1.3.3 Market Breakdown and Data Triangulation
      • 1.3.4 Base Year
      • 1.3.5 Report Assumptions & Caveats
  • 2 Continuous Subcutaneous Insulin Infusion Devices Market Overview
    • 2.1 Global Market Overview
      • 2.1.1 Global Continuous Subcutaneous Insulin Infusion Devices Market Size (M USD) Estimates and Forecasts (2020-2035)
      • 2.1.2 Global Continuous Subcutaneous Insulin Infusion Devices Sales Estimates and Forecasts (2020-2035)
    • 2.2 Market Segment Executive Summary
    • 2.3 Global Market Size by Region
  • 3 Continuous Subcutaneous Insulin Infusion Devices Market Competitive Landscape
    • 3.1 Company Assessment Quadrant
    • 3.2 Global Continuous Subcutaneous Insulin Infusion Devices Product Life Cycle
    • 3.3 Global Continuous Subcutaneous Insulin Infusion Devices Sales by Manufacturers (2020-2025)
    • 3.4 Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Manufacturers (2020-2025)
    • 3.5 Continuous Subcutaneous Insulin Infusion Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.6 Global Continuous Subcutaneous Insulin Infusion Devices Average Price by Manufacturers (2020-2025)
    • 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
    • 3.8 Continuous Subcutaneous Insulin Infusion Devices Market Competitive Situation and Trends
      • 3.8.1 Continuous Subcutaneous Insulin Infusion Devices Market Concentration Rate
      • 3.8.2 Global 5 and 10 Largest Continuous Subcutaneous Insulin Infusion Devices Players Market Share by Revenue
      • 3.8.3 Mergers & Acquisitions, Expansion
  • 4 Continuous Subcutaneous Insulin Infusion Devices Industry Chain Analysis
    • 4.1 Continuous Subcutaneous Insulin Infusion Devices Industry Chain Analysis
    • 4.2 Market Overview of Key Raw Materials
    • 4.3 Midstream Market Analysis
    • 4.4 Downstream Customer Analysis
  • 5 The Development and Dynamics of Continuous Subcutaneous Insulin Infusion Devices Market
    • 5.1 Key Development Trends
    • 5.2 Driving Factors
    • 5.3 Market Challenges
    • 5.4 Industry News
      • 5.4.1 New Product Developments
      • 5.4.2 Mergers & Acquisitions
      • 5.4.3 Expansions
      • 5.4.4 Collaboration/Supply Contracts
    • 5.5 PEST Analysis
      • 5.5.1 Industry Policies Analysis
      • 5.5.2 Economic Environment Analysis
      • 5.5.3 Social Environment Analysis
      • 5.5.4 Technological Environment Analysis
    • 5.6 Global Continuous Subcutaneous Insulin Infusion Devices Market Porters Five Forces Analysis
      • 5.6.1 Global Trade Frictions
      • 5.6.2 U.S. Tariff Policy – April 2025
      • 5.6.3 Global Trade Frictions and Their Impacts to Continuous Subcutaneous Insulin Infusion Devices Market
    • 5.7 ESG Ratings of Leading Companies
  • 6 Continuous Subcutaneous Insulin Infusion Devices Market Segmentation by Type
    • 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
    • 6.2 Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Type (2020-2025)
    • 6.3 Global Continuous Subcutaneous Insulin Infusion Devices Market Size by Type (2020-2025)
    • 6.4 Global Continuous Subcutaneous Insulin Infusion Devices Price by Type (2020-2025)
  • 7 Continuous Subcutaneous Insulin Infusion Devices Market Segmentation by Application
    • 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
    • 7.2 Global Continuous Subcutaneous Insulin Infusion Devices Market Sales by Application (2020-2025)
    • 7.3 Global Continuous Subcutaneous Insulin Infusion Devices Market Size (M USD) by Application (2020-2025)
    • 7.4 Global Continuous Subcutaneous Insulin Infusion Devices Sales Growth Rate by Application (2020-2025)
  • 8 Continuous Subcutaneous Insulin Infusion Devices Market Sales by Region
    • 8.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales by Region
      • 8.1.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales by Region
      • 8.1.2 Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Region
    • 8.2 Global Continuous Subcutaneous Insulin Infusion Devices Market Size by Region
      • 8.2.1 Global Continuous Subcutaneous Insulin Infusion Devices Market Size by Region
      • 8.2.2 Global Continuous Subcutaneous Insulin Infusion Devices Market Size by Region
    • 8.3 North America
      • 8.3.1 North America Continuous Subcutaneous Insulin Infusion Devices Sales by Country
      • 8.3.2 North America Continuous Subcutaneous Insulin Infusion Devices Market Size by Country
      • 8.3.3 U.S. Market Overview
      • 8.3.4 Canada Market Overview
      • 8.3.5 Mexico Market Overview
    • 8.4 Europe
      • 8.4.1 Europe Continuous Subcutaneous Insulin Infusion Devices Sales by Country
      • 8.4.2 Europe Continuous Subcutaneous Insulin Infusion Devices Market Size by Country
      • 8.4.3 Germany Market Overview
      • 8.4.4 France Market Overview
      • 8.4.5 U.K. Market Overview
      • 8.4.6 Italy Market Overview
      • 8.4.7 Spain Market Overview
    • 8.5 Asia Pacific
      • 8.5.1 Asia Pacific Continuous Subcutaneous Insulin Infusion Devices Sales by Region
      • 8.5.2 Asia Pacific Continuous Subcutaneous Insulin Infusion Devices Market Size by Region
      • 8.5.3 China Market Overview
      • 8.5.4 Japan Market Overview
      • 8.5.5 South Korea Market Overview
      • 8.5.6 India Market Overview
      • 8.5.7 Southeast Asia Market Overview
    • 8.6 South America
      • 8.6.1 South America Continuous Subcutaneous Insulin Infusion Devices Sales by Country
      • 8.6.2 South America Continuous Subcutaneous Insulin Infusion Devices Market Size by Country
      • 8.6.3 Brazil Market Overview
      • 8.6.4 Argentina Market Overview
      • 8.6.5 Columbia Market Overview
    • 8.7 Middle East and Africa
      • 8.7.1 Middle East and Africa Continuous Subcutaneous Insulin Infusion Devices Sales by Region
      • 8.7.2 Middle East and Africa Continuous Subcutaneous Insulin Infusion Devices Market Size by Region
      • 8.7.3 Saudi Arabia Market Overview
      • 8.7.4 UAE Market Overview
      • 8.7.5 Egypt Market Overview
      • 8.7.6 Nigeria Market Overview
      • 8.7.7 South Africa Market Overview
  • 9 Continuous Subcutaneous Insulin Infusion Devices Market Production by Region
    • 9.1 Global Production of Continuous Subcutaneous Insulin Infusion Devices by Region(2020-2025)
    • 9.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Region (2020-2025)
    • 9.3 Global Continuous Subcutaneous Insulin Infusion Devices Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.4 North America Continuous Subcutaneous Insulin Infusion Devices Production
      • 9.4.1 North America Continuous Subcutaneous Insulin Infusion Devices Production Growth Rate (2020-2025)
      • 9.4.2 North America Continuous Subcutaneous Insulin Infusion Devices Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.5 Europe Continuous Subcutaneous Insulin Infusion Devices Production
      • 9.5.1 Europe Continuous Subcutaneous Insulin Infusion Devices Production Growth Rate (2020-2025)
      • 9.5.2 Europe Continuous Subcutaneous Insulin Infusion Devices Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.6 Japan Continuous Subcutaneous Insulin Infusion Devices Production (2020-2025)
      • 9.6.1 Japan Continuous Subcutaneous Insulin Infusion Devices Production Growth Rate (2020-2025)
      • 9.6.2 Japan Continuous Subcutaneous Insulin Infusion Devices Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.7 China Continuous Subcutaneous Insulin Infusion Devices Production (2020-2025)
      • 9.7.1 China Continuous Subcutaneous Insulin Infusion Devices Production Growth Rate (2020-2025)
      • 9.7.2 China Continuous Subcutaneous Insulin Infusion Devices Production, Revenue, Price and Gross Margin (2020-2025)
  • 10 Key Companies Profile
    • 10.1 Medtronic
      • 10.1.1 Medtronic Basic Information
      • 10.1.2 Medtronic Continuous Subcutaneous Insulin Infusion Devices Product Overview
      • 10.1.3 Medtronic Continuous Subcutaneous Insulin Infusion Devices Product Market Performance
      • 10.1.4 Medtronic Business Overview
      • 10.1.5 Medtronic SWOT Analysis
      • 10.1.6 Medtronic Recent Developments
    • 10.2 Roche
      • 10.2.1 Roche Basic Information
      • 10.2.2 Roche Continuous Subcutaneous Insulin Infusion Devices Product Overview
      • 10.2.3 Roche Continuous Subcutaneous Insulin Infusion Devices Product Market Performance
      • 10.2.4 Roche Business Overview
      • 10.2.5 Roche SWOT Analysis
      • 10.2.6 Roche Recent Developments
    • 10.3 Insulet Corp
      • 10.3.1 Insulet Corp Basic Information
      • 10.3.2 Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Product Overview
      • 10.3.3 Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Product Market Performance
      • 10.3.4 Insulet Corp Business Overview
      • 10.3.5 Insulet Corp SWOT Analysis
      • 10.3.6 Insulet Corp Recent Developments
    • 10.4 Tandem Diabetes care
      • 10.4.1 Tandem Diabetes care Basic Information
      • 10.4.2 Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Product Overview
      • 10.4.3 Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Product Market Performance
      • 10.4.4 Tandem Diabetes care Business Overview
      • 10.4.5 Tandem Diabetes care Recent Developments
    • 10.5 Valeritas
      • 10.5.1 Valeritas Basic Information
      • 10.5.2 Valeritas Continuous Subcutaneous Insulin Infusion Devices Product Overview
      • 10.5.3 Valeritas Continuous Subcutaneous Insulin Infusion Devices Product Market Performance
      • 10.5.4 Valeritas Business Overview
      • 10.5.5 Valeritas Recent Developments
    • 10.6 SOOIL
      • 10.6.1 SOOIL Basic Information
      • 10.6.2 SOOIL Continuous Subcutaneous Insulin Infusion Devices Product Overview
      • 10.6.3 SOOIL Continuous Subcutaneous Insulin Infusion Devices Product Market Performance
      • 10.6.4 SOOIL Business Overview
      • 10.6.5 SOOIL Recent Developments
    • 10.7 Microport
      • 10.7.1 Microport Basic Information
      • 10.7.2 Microport Continuous Subcutaneous Insulin Infusion Devices Product Overview
      • 10.7.3 Microport Continuous Subcutaneous Insulin Infusion Devices Product Market Performance
      • 10.7.4 Microport Business Overview
      • 10.7.5 Microport Recent Developments
  • 11 Continuous Subcutaneous Insulin Infusion Devices Market Forecast by Region
    • 11.1 Global Continuous Subcutaneous Insulin Infusion Devices Market Size Forecast
    • 11.2 Global Continuous Subcutaneous Insulin Infusion Devices Market Forecast by Region
      • 11.2.1 North America Market Size Forecast by Country
      • 11.2.2 Europe Continuous Subcutaneous Insulin Infusion Devices Market Size Forecast by Country
      • 11.2.3 Asia Pacific Continuous Subcutaneous Insulin Infusion Devices Market Size Forecast by Region
      • 11.2.4 South America Continuous Subcutaneous Insulin Infusion Devices Market Size Forecast by Country
      • 11.2.5 Middle East and Africa Forecasted Sales of Continuous Subcutaneous Insulin Infusion Devices by Country
  • 12 Forecast Market by Type and by Application (2026-2035)
    • 12.1 Global Continuous Subcutaneous Insulin Infusion Devices Market Forecast by Type (2026-2035)
      • 12.1.1 Global Forecasted Sales of Continuous Subcutaneous Insulin Infusion Devices by Type (2026-2035)
      • 12.1.2 Global Continuous Subcutaneous Insulin Infusion Devices Market Size Forecast by Type (2026-2035)
      • 12.1.3 Global Forecasted Price of Continuous Subcutaneous Insulin Infusion Devices by Type (2026-2035)
    • 12.2 Global Continuous Subcutaneous Insulin Infusion Devices Market Forecast by Application (2026-2035)
      • 12.2.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales (K Units) Forecast by Application
      • 12.2.2 Global Continuous Subcutaneous Insulin Infusion Devices Market Size (M USD) Forecast by Application (2026-2035)
  • 13 Conclusion and Key Findings

Frequently Asked Questions

JSB Market Research is a global provider of market research reports, industry insights, and business intelligence solutions. We help companies, analysts, and decision-makers gain a deeper understanding of global and regional markets.

Our reports deliver data-driven insights, market opportunities, competitive landscapes, and future forecasts. These help your business make informed decisions, enter new markets confidently, and stay ahead of industry trends.

Yes. We offer tailored research services designed to meet your specific market, product, or competitor analysis needs. Our experts work closely with clients to deliver precise, relevant, and actionable insights.

Browse the desired report, select your preferred license type, and complete payment through our secure checkout. For corporate purchases or invoice payments, you can contact our support team directly.

Yes. You can request sample pages or a report overview. This helps you understand the structure, methodology, and depth of analysis before purchasing.